NDA Review Times Are Down 55 Days, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
FDA is just five days short of its goal of reducing average NDA review time by 60 days, the agency reports
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning